Study Of Anti-IGF-IR CP-751,871 In Patients With Solid Tumors

Clinical trial NCT00474760 · COMPLETED

Trial details

NCT number: NCT00474760
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Sarcoma, Ewing's

Start date: 2005-08-01
Primary completion: 2011-01-01
Enrollment: 65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.